Researchers from Norway are involved in 3 large studies that will receive funding from the EU initiative for neurodegenerative disease research, the JPND. One of the studies is led by NNN member Tormod Fladby at Akershus University Hospital (Ahus). 

Under the slogan "for PhD students, by PhD students", 92 PhD candidates from all over Norway gathered at the historic site of Stiklestad for the first National PhD Conference in Neuroscience. 

Norwegian researchers are involved in developing a new MR imaging technique, vessel architectural imaging (VAI), which offers insights into the treatment of patients with brain tumour. 

The working groups for HelseOmsorg21 ask for input on the future research and innovation strategy for the healthcare sector. The window for providing input opens today and closes on October 14th

Researchers at MIT have successfully implanted false memories in mice by manipulating neurons that are responsible for establishing memory. 

In a new meta-study, Norwegian researchers have looked at how magnetic resonance imaging (MRI) can detect changes in the volumes of different brain structures in Schizophrenia.

Behind the international consensus on EEG interpretation published in Epilepsia this summer, is the system developed and marketed by NNN member company Holberg EEG. 

NNN member Smartfish is a company developing omega-3 based pharmaconutrition products. A study presented at the Alzheimer’s Association International Conference in Boston in July, could potentially link a Smartfish drink to prevention of Alzheimer’s disease.